These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 10861276)

  • 81. Immune recognition of linear antigenic regions within the hepatitis B pre-C and C-gene translation products using synthetic peptides.
    Sällberg M; Rudén U; Wahren B; Magnius LO
    J Med Virol; 1994 Jan; 42(1):7-15. PubMed ID: 7508491
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Induction of strong hepatitis B virus (HBV) specific T helper cell and cytotoxic T lymphocyte responses by therapeutic vaccination in the trimera mouse model of chronic HBV infection.
    Böcher WO; Dekel B; Schwerin W; Geissler M; Hoffmann S; Rohwer A; Arditti F; Cooper A; Bernhard H; Berrebi A; Rose-John S; Shaul Y; Galle PR; Löhr HF; Reisner Y
    Eur J Immunol; 2001 Jul; 31(7):2071-9. PubMed ID: 11449360
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Identification of hepatitis B virus-specific CTL epitopes presented by HLA-A*2402, the most common HLA class I allele in East Asia.
    Sobao Y; Sugi K; Tomiyama H; Saito S; Fujiyama S; Morimoto M; Hasuike S; Tsubouchi H; Tanaka K; Takiguch M
    J Hepatol; 2001 Jun; 34(6):922-9. PubMed ID: 11451178
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Antibody and cytotoxic T-cell responses to soluble hepatitis B virus (HBV) S antigen in mice: implication for the pathogenesis of HBV-induced hepatitis.
    Schirmbeck R; Melber K; Mertens T; Reimann J
    J Virol; 1994 Mar; 68(3):1418-25. PubMed ID: 8107205
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Dynamic profile of the HBeAg-anti-HBe system in acute and chronic hepatitis B virus infection: A clinical-laboratory approach.
    de Almeida Pondé RA
    Mol Biol Rep; 2021 Jan; 48(1):843-854. PubMed ID: 33296069
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Identification and functional studies of HLA-A0201 restricted CTL epitopes in the X protein of hepatitis B virus.
    Guo YJ; Zhu Y; Sun SH
    Acta Virol; 2011; 55(2):107-15. PubMed ID: 21692558
    [TBL] [Abstract][Full Text] [Related]  

  • 87. The L60V variation in hepatitis B virus core protein elicits new epitope-specific cytotoxic T lymphocytes and enhances viral replication.
    Zhang Y; Ren Y; Wu Y; Zhao B; Qiu L; Li X; Xu D; Liu J; Gao GF; Meng S
    J Virol; 2013 Jul; 87(14):8075-84. PubMed ID: 23678186
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Analysis of clinical characteristics and S gene sequences in chronic asymptomatic HBV carriers with low-level HBsAg.
    Wang T; Cui D; Chen S; Xu X; Sun C; Dai Y; Cheng J
    Clin Res Hepatol Gastroenterol; 2019 Apr; 43(2):179-189. PubMed ID: 30293895
    [TBL] [Abstract][Full Text] [Related]  

  • 89. A new unconventional HLA-A2-restricted epitope from HBV core protein elicits antiviral cytotoxic T lymphocytes.
    Sun L; Zhang Y; Zhao B; Deng M; Liu J; Li X; Hou J; Gui M; Zhang S; Li X; Gao GF; Meng S
    Protein Cell; 2014 Apr; 5(4):317-27. PubMed ID: 24659387
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Hierarchy of Epstein-Barr virus-specific cytotoxic T-cell responses in individuals carrying different subtypes of an HLA allele: implications for epitope-based antiviral vaccines.
    Khanna R; Burrows SR; Neisig A; Neefjes J; Moss DJ; Silins SL
    J Virol; 1997 Oct; 71(10):7429-35. PubMed ID: 9311821
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Human and murine B-cells recognize the HBeAg/beta (or HBe2) epitope as a linear determinant.
    Sällberg M; Rudén U; Wahren B; Noah M; Magnius LO
    Mol Immunol; 1991 Jul; 28(7):719-26. PubMed ID: 1713295
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Induction of an antigen-specific CTL response by a conformationally biased agonist of human C5a anaphylatoxin as a molecular adjuvant.
    Ulrich JT; Cieplak W; Paczkowski NJ; Taylor SM; Sanderson SD
    J Immunol; 2000 May; 164(10):5492-8. PubMed ID: 10799917
    [TBL] [Abstract][Full Text] [Related]  

  • 93. An immunodominant HLA-A*1101-restricted CD8+ T-cell response targeting hepatitis B surface antigen in chronic hepatitis B patients.
    Chen X; Wang W; Wang S; Meng G; Zhang M; Ni B; Wu Y; Wang L
    J Gen Virol; 2013 Dec; 94(Pt 12):2717-2723. PubMed ID: 23997182
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Identification of novel HLA-A*0201-restricted CD8+ T-cell epitopes on hepatitis delta virus.
    Huang YH; Tao MH; Hu CP; Syu WJ; Wu JC
    J Gen Virol; 2004 Oct; 85(Pt 10):3089-3098. PubMed ID: 15448372
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Hepatitis B virus (HBV)-specific cytotoxic T-cell response in humans: production of target cells by stable expression of HBV-encoded proteins in immortalized human B-cell lines.
    Guilhot S; Fowler P; Portillo G; Margolskee RF; Ferrari C; Bertoletti A; Chisari FV
    J Virol; 1992 May; 66(5):2670-8. PubMed ID: 1313893
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Tumor eradication by hepatitis B virus X antigen-specific CD8+ T cells in xenografted nude mice.
    Chun E; Lee J; Cheong HS; Lee KY
    J Immunol; 2003 Feb; 170(3):1183-90. PubMed ID: 12538674
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Discovery and Selection of Hepatitis B Virus-Derived T Cell Epitopes for Global Immunotherapy Based on Viral Indispensability, Conservation, and HLA-Binding Strength.
    de Beijer MTA; Jansen DTSL; Dou Y; van Esch WJE; Mok JY; Maas MJP; Brasser G; de Man RA; Woltman AM; Buschow SI
    J Virol; 2020 Mar; 94(7):. PubMed ID: 31852786
    [TBL] [Abstract][Full Text] [Related]  

  • 98. HLA class I antigen display on hepatocyte membrane in chronic hepatitis B virus infection: its role in the pathogenesis of chronic type B hepatitis.
    Chu CM; Shyu WC; Kuo RW; Liaw YF
    Hepatology; 1988; 8(3):712-7. PubMed ID: 3286466
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Quantitative and functional analysis of core-specific T-helper cell and CTL activities in acute and chronic hepatitis B.
    Löhr HF; Krug S; Herr W; Weyer S; Schlaak J; Wölfel T; Gerken G; Meyer zum Büschenfelde KH
    Liver; 1998 Dec; 18(6):405-13. PubMed ID: 9869395
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Evolution of viral quasispecies in four dominant HlA-A2 restricted T cell epitopes is not a major reason for viral persistence in interferon-treated patients with chronic hepatitis C.
    Pingel S; Weyer S; Galle PR; Löhr HF
    J Med Virol; 2002 Apr; 66(4):472-80. PubMed ID: 11857524
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.